NEW YORK (GenomeWeb) – Cowen and JP Morgan both initiated coverage of Twist Bioscience today, citing the company's leadership role in the synthetic biology market and its ability to manufacture DNA cheaply and at scale using its commercial platform.

While Cowen assigned the company's shares a rating of Outperform, JP Morgan analyst Tycho Peterson gave them a more conservative rating of Neutral, saying in a note to investors that the stock's value has essentially doubled after the firm's initial public offering, prompting JP Morgan to wait for a more opportunistic entry point.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.